Oncotelic Initiates Clinical Trials Evaluating OT-101 against Pediatric Gliomas
08 nov. 2022 07h33 HE
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or “We”), a developer of treatments for rare and orphan indications,...